Your browser doesn't support javascript.
loading
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement.
Pijnappel, Esther N; Suurmeijer, J Annelie; Koerkamp, Bas Groot; Kos, Milan; Siveke, Jens T; Salvia, Roberto; Ghaneh, Paula; van Eijck, Casper H J; van Etten-Jamaludin, Faridi S; Abrams, Ross; Brasiuniene, Birute; Büchler, Markus W; Casadei, Riccardo; van Laethem, Jean-Luc; Berlin, Jordan; Boku, Narikazu; Conroy, Thierry; Golcher, Henriette; Sinn, Marianne; Neoptolemos, John P; van Tienhoven, Geertjan; Besselink, Marc G; Wilmink, Johanna W; van Laarhoven, Hanneke W M.
Afiliação
  • Pijnappel EN; Department of Medical Oncology, Cancer Center, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Suurmeijer JA; Department of Surgery, Cancer Center, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Koerkamp BG; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Kos M; Department of Medical Oncology, Cancer Center, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Siveke JT; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany.
  • Salvia R; Division of Solid Tumor Translational Oncology, German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.
  • Ghaneh P; Department of Surgery, Verona University, Verona, Italy.
  • van Eijck CHJ; Department of Molecular and Clinical Cancer Medicine University of Liverpool, Liverpool, UK.
  • van Etten-Jamaludin FS; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Abrams R; Research Support, Medical Library, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Brasiuniene B; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.
  • Büchler MW; Department of Medical Oncology, National Cancer Institute, Faculty of Medicine, Vilnius University, Lithuania.
  • Casadei R; Department of General Surgery, University of Heidelberg, Heidelberg, Germany.
  • van Laethem JL; Dipartimento di Scienze Mediche e Chirurgiche, Bologna, Italy.
  • Berlin J; Department of Gastroenterology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Boku N; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, US.
  • Conroy T; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Golcher H; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.
  • Sinn M; Department of Surgery, University Hospital Erlangen, Erlangen, Germany.
  • Neoptolemos JP; Charite-Universitatsmedizin Berlin, CONKO study group, Berlin, Germany.
  • van Tienhoven G; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
  • Besselink MG; Department of General Surgery, University of Heidelberg, Heidelberg, Germany.
  • Wilmink JW; Department of Radiation Oncology, Cancer Center, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • van Laarhoven HWM; Department of Surgery, Cancer Center, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
JAMA Oncol ; 8(6): 929-937, 2022 06 01.
Article em En | MEDLINE | ID: mdl-35446336
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article